Castleview Partners’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-778
Closed -$12K 851
2024
Q2
$12K Buy
778
+16
+2% +$229 0.01% 492
2024
Q1
$11.3K Buy
762
+16
+2% +$222 0.01% 531
2023
Q4
$10.6K Buy
+746
New +$10.6K 0.01% 509
2022
Q4
Sell
-661
Closed -$9K 700
2022
Q3
$9K Buy
661
+548
+485% +$8.1K 0.01% 399
2022
Q2
$3.5K Sell
113
-521
-82% -$6.97K ﹤0.01% 582
2022
Q1
$9K Buy
+634
New +$8.68K 0.01% 510
2021
Q2
$0 Buy
+11
New +$196 ﹤0.01% 904

Other funds holding SBRA

Castleview Partners's SBRA Position: Q3 2024 in Review

Castleview Partners sold out of Sabra Healthcare REIT (SBRA) in Q3 2024, closing a stake of 778 shares — an estimated $12K sold.

Castleview Partners first reported a position in SBRA in Q2 2021 and held it in 7 quarters. The position peaked at $12K in Q2 2024. 379 funds tracked by Wall St. Rank hold SBRA as of Q3 2024.

  • Castleview Partners reported no remaining Sabra Healthcare REIT position as of Q3 2024 after selling out during the quarter.
  • Castleview Partners sold 778 Sabra Healthcare REIT shares in Q3 2024, an estimated $12K.
  • Castleview Partners first reported a position in Sabra Healthcare REIT in Q2 2021 and held it in 7 quarters.
  • Castleview Partners's Sabra Healthcare REIT position peaked at $12K in Q2 2024.
  • 379 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2024.

Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.